Catalyst dives as FDA approves rival's rare disease drug

Submitted by admin on May 7, 2019 - 6:58pm

Source:

Biopharma Dive

News Tags:

FDA

Catalyst Pharmaceutical Partners

Jacobus Pharmaceuticals

Ruzurgi

Firdapse

LEMS

Headline:

Catalyst dives as FDA approves rival's rare disease drug

snippet:

The Food and Drug Administration has approved a rare disease drug from family-owned Jacobus Pharmaceutical, a decision that could present a competitive threat to Catalyst Pharmaceuticals.

Search form

You are here

Catalyst dives as FDA approves rival's rare disease drug

Catalyst dives as FDA approves rival's rare disease drug